Management of chronic pulmonary aspergillosis

Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus

(2012) Masato Tashiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Failure of Posaconazole Therapy in a Renal Transplant Patient with Invasive Aspergillosis Due to Aspergillus fumigatus with Attenuated Susceptibility to Posaconazole

(2011) Saskia Kuipers et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan

(2011) Masato Tashiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene

(2011) Shawn R. Lockhart et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole resistance inAspergillus: a growing public health menace

(2011) David W Denning et al.   Future Microbiology

Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India

(2011) A. Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis

(2010) Timothy W. Felton et al.   CLINICAL INFECTIOUS DISEASES

Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma

(2010) N. L. Smith et al.   EUROPEAN RESPIRATORY JOURNAL

Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy

(2010) Adelina Amorim et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

(2010) A. Bueid et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: A multicenter trial in Japan

(2010) Shigeru Kohno et al.   JOURNAL OF INFECTION

Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma

(2010) Bahrie Bellete et al.   MEDICAL MYCOLOGY

The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982 - 1987)/Die Behandlung der Aspergillose und des Aspergilloms mit Itraconazol, Klinische Ergebnisse einer offenen internationalen Studi

(2010) K. Beule et al.   MYCOSES

PULMONARY ASPERGILLOSIS CAUSED BY A PAN-AZOLE-RESISTANT ASPERGILLUS FUMIGATUS IN A 10-YEAR-OLD BOY

(2010) Valtyr S. Thors et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence

(2010) Maiken Cavling Arendrup et al.   PLoS One

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

(2009) E. Snelders et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis

(2009) S.J. Howard et al.   CLINICAL MICROBIOLOGY AND INFECTION

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

(2009) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases

(2009) Hae-Seong Nam et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

(2009) J. W. Baddley et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

(2009) Paul E Verweij et al.   LANCET INFECTIOUS DISEASES

Comparison ofAspergillusgalactomannan antigen testing with a new cut-off index andAspergillusprecipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis

(2009) Yasuhiko KITASATO et al.   RESPIROLOGY

Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era

(2008) J. Guinea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus

(2008) J. L. Rodriguez-Tudela et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds

(2008)   CLINICAL MICROBIOLOGY AND INFECTION

Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies

(2008) A. Espinel-Ingroff et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype

(2008) Leah E. Cowen   NATURE REVIEWS MICROBIOLOGY

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

(2008) Eveline Snelders et al.   PLOS MEDICINE